Farid Ramy

Farid Ramy is listed in filings as Director at Vir Biotechnology, Inc.. This profile follows SEC Form 4 activity through May 28, 2026, including sale activity. Recent filings connect the profile to Vir Biotechnology, Inc. (VIR) and Schrödinger, Inc. (SDGR). The current snapshot covers public activity from Mar 4, 2025 to May 28, 2026. Reported amounts are shown as $145.6K to $228.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.